However, even though both luminal A and luminal B breast cancers are ER-positive, luminal B cancers have a considerably worse prognosis, with overall survival in untreated tumors similar to that of the HER2-positive and basal types [2]. This evidence concerns the gene ESR1 and breast carcinoma.